Clinical use of the long acting somatostatin analogue octreotide in pediatrics
| ISSN: |
1432-1076
|
|---|---|
| Keywords: |
Octreotide ; Long acting somatostatin analog ; Indications in gastroenterology ; Treatment of tall stature ; Nesidioblastosis
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Abstract Preliminary data of the use of the long-acting somatostatin analog octreotide (Sandostatin) in pediatrics are reported. In nesidioblastosis and other hyperinsulinemic conditions, timely treatment with octreotide can protect cerebral function and may reduce mortality. The acure use of octreotide produces prompt elevation of blood glucose, even in patients who fail to respond to diazoxide. In addition, it may be possible to avoid the need for partial or subtotal pancreatectomy by the long-term use of octreotide. As in adults, octreotide should find a place in the symptomatic treatment of secretory diarrhea, notably the watery diarrheahypokalemia-achlorhydria complex and pancreatic cholera syndrome. Octreotide has been shown to be effective in the treatment of familial tall stature by reducing height velocity and final height. Responses to octreotide therapy vary and the individual responsiveness must be extensively studied.
|
| Type of Medium: |
Electronic Resource
|
| URL: |
| _version_ | 1798295578955743232 |
|---|---|
| autor | Tauber, M. T. Harris, A. G. Rochiccioli, P. |
| autorsonst | Tauber, M. T. Harris, A. G. Rochiccioli, P. |
| book_url | http://dx.doi.org/10.1007/BF01956407 |
| datenlieferant | nat_lic_papers |
| hauptsatz | hsatz_simple |
| identnr | NLM205192696 |
| issn | 1432-1076 |
| journal_name | European journal of pediatrics |
| materialart | 1 |
| notes | Abstract Preliminary data of the use of the long-acting somatostatin analog octreotide (Sandostatin) in pediatrics are reported. In nesidioblastosis and other hyperinsulinemic conditions, timely treatment with octreotide can protect cerebral function and may reduce mortality. The acure use of octreotide produces prompt elevation of blood glucose, even in patients who fail to respond to diazoxide. In addition, it may be possible to avoid the need for partial or subtotal pancreatectomy by the long-term use of octreotide. As in adults, octreotide should find a place in the symptomatic treatment of secretory diarrhea, notably the watery diarrheahypokalemia-achlorhydria complex and pancreatic cholera syndrome. Octreotide has been shown to be effective in the treatment of familial tall stature by reducing height velocity and final height. Responses to octreotide therapy vary and the individual responsiveness must be extensively studied. |
| package_name | Springer |
| publikationsjahr_anzeige | 1994 |
| publikationsjahr_facette | 1994 |
| publikationsjahr_intervall | 8009:1990-1994 |
| publikationsjahr_sort | 1994 |
| publisher | Springer |
| reference | 153 (1994), S. 304-310 |
| schlagwort | Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis |
| search_space | articles |
| shingle_author_1 | Tauber, M. T. Harris, A. G. Rochiccioli, P. |
| shingle_author_2 | Tauber, M. T. Harris, A. G. Rochiccioli, P. |
| shingle_author_3 | Tauber, M. T. Harris, A. G. Rochiccioli, P. |
| shingle_author_4 | Tauber, M. T. Harris, A. G. Rochiccioli, P. |
| shingle_catch_all_1 | Tauber, M. T. Harris, A. G. Rochiccioli, P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Abstract Preliminary data of the use of the long-acting somatostatin analog octreotide (Sandostatin) in pediatrics are reported. In nesidioblastosis and other hyperinsulinemic conditions, timely treatment with octreotide can protect cerebral function and may reduce mortality. The acure use of octreotide produces prompt elevation of blood glucose, even in patients who fail to respond to diazoxide. In addition, it may be possible to avoid the need for partial or subtotal pancreatectomy by the long-term use of octreotide. As in adults, octreotide should find a place in the symptomatic treatment of secretory diarrhea, notably the watery diarrheahypokalemia-achlorhydria complex and pancreatic cholera syndrome. Octreotide has been shown to be effective in the treatment of familial tall stature by reducing height velocity and final height. Responses to octreotide therapy vary and the individual responsiveness must be extensively studied. 1432-1076 14321076 Springer |
| shingle_catch_all_2 | Tauber, M. T. Harris, A. G. Rochiccioli, P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Abstract Preliminary data of the use of the long-acting somatostatin analog octreotide (Sandostatin) in pediatrics are reported. In nesidioblastosis and other hyperinsulinemic conditions, timely treatment with octreotide can protect cerebral function and may reduce mortality. The acure use of octreotide produces prompt elevation of blood glucose, even in patients who fail to respond to diazoxide. In addition, it may be possible to avoid the need for partial or subtotal pancreatectomy by the long-term use of octreotide. As in adults, octreotide should find a place in the symptomatic treatment of secretory diarrhea, notably the watery diarrheahypokalemia-achlorhydria complex and pancreatic cholera syndrome. Octreotide has been shown to be effective in the treatment of familial tall stature by reducing height velocity and final height. Responses to octreotide therapy vary and the individual responsiveness must be extensively studied. 1432-1076 14321076 Springer |
| shingle_catch_all_3 | Tauber, M. T. Harris, A. G. Rochiccioli, P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Abstract Preliminary data of the use of the long-acting somatostatin analog octreotide (Sandostatin) in pediatrics are reported. In nesidioblastosis and other hyperinsulinemic conditions, timely treatment with octreotide can protect cerebral function and may reduce mortality. The acure use of octreotide produces prompt elevation of blood glucose, even in patients who fail to respond to diazoxide. In addition, it may be possible to avoid the need for partial or subtotal pancreatectomy by the long-term use of octreotide. As in adults, octreotide should find a place in the symptomatic treatment of secretory diarrhea, notably the watery diarrheahypokalemia-achlorhydria complex and pancreatic cholera syndrome. Octreotide has been shown to be effective in the treatment of familial tall stature by reducing height velocity and final height. Responses to octreotide therapy vary and the individual responsiveness must be extensively studied. 1432-1076 14321076 Springer |
| shingle_catch_all_4 | Tauber, M. T. Harris, A. G. Rochiccioli, P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Octreotide Long acting somatostatin analog Indications in gastroenterology Treatment of tall stature Nesidioblastosis Abstract Preliminary data of the use of the long-acting somatostatin analog octreotide (Sandostatin) in pediatrics are reported. In nesidioblastosis and other hyperinsulinemic conditions, timely treatment with octreotide can protect cerebral function and may reduce mortality. The acure use of octreotide produces prompt elevation of blood glucose, even in patients who fail to respond to diazoxide. In addition, it may be possible to avoid the need for partial or subtotal pancreatectomy by the long-term use of octreotide. As in adults, octreotide should find a place in the symptomatic treatment of secretory diarrhea, notably the watery diarrheahypokalemia-achlorhydria complex and pancreatic cholera syndrome. Octreotide has been shown to be effective in the treatment of familial tall stature by reducing height velocity and final height. Responses to octreotide therapy vary and the individual responsiveness must be extensively studied. 1432-1076 14321076 Springer |
| shingle_title_1 | Clinical use of the long acting somatostatin analogue octreotide in pediatrics |
| shingle_title_2 | Clinical use of the long acting somatostatin analogue octreotide in pediatrics |
| shingle_title_3 | Clinical use of the long acting somatostatin analogue octreotide in pediatrics |
| shingle_title_4 | Clinical use of the long acting somatostatin analogue octreotide in pediatrics |
| sigel_instance_filter | dkfz geomar wilbert ipn albert fhp |
| source_archive | Springer Online Journal Archives 1860-2000 |
| timestamp | 2024-05-06T09:38:26.388Z |
| titel | Clinical use of the long acting somatostatin analogue octreotide in pediatrics |
| titel_suche | Clinical use of the long acting somatostatin analogue octreotide in pediatrics |
| topic | WW-YZ |
| uid | nat_lic_papers_NLM205192696 |